Your browser doesn't support javascript.
loading
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Ostrominski, John W; Vaduganathan, Muthiah; Selvaraj, Senthil; Claggett, Brian L; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Kosiborod, Mikhail N; Lam, Carolyn S P; Inzucchi, Silvio E; Martinez, Felipe A; de Boer, Rudolf A; Hernandez, Adrian F; Shah, Sanjiv J; Petersson, Magnus; Maria Langkilde, Anna; McMurray, John J V; Solomon, Scott D.
Afiliação
  • Ostrominski JW; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V., B.L.C., Z.M.M., A.S.D., S.D.S.).
  • Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V., B.L.C., Z.M.M., A.S.D., S.D.S.).
  • Selvaraj S; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.S., A.F.H.).
  • Claggett BL; Duke Molecular Physiology Institute, Durham, NC (S.S.).
  • Miao ZM; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V., B.L.C., Z.M.M., A.S.D., S.D.S.).
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V., B.L.C., Z.M.M., A.S.D., S.D.S.).
  • Jhund PS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V., B.L.C., Z.M.M., A.S.D., S.D.S.).
  • Kosiborod MN; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (P.S.J., J.J.V.M.).
  • Lam CSP; St Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.).
  • Inzucchi SE; National Heart Centre Singapore and Duke-National University of Singapore (C.S.P.L.).
  • Martinez FA; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.).
  • de Boer RA; Universidad Nacional de Córdoba, Argentina (F.A.M.).
  • Hernandez AF; Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.).
  • Shah SJ; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.S., A.F.H.).
  • Petersson M; Duke Clinical Research Institute, Duke University, Durham, NC (A.F.H.).
  • Maria Langkilde A; Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).
  • McMurray JJV; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (M.P., A.M.L.).
  • Solomon SD; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (M.P., A.M.L.).
Circulation ; 148(24): 1945-1957, 2023 12 12.
Article em En | MEDLINE | ID: mdl-37830208
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Hipertensão Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Hipertensão Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article